ID

31433

Descripción

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00862303

Link

https://clinicaltrials.gov/show/NCT00862303

Palabras clave

  1. 21/8/18 21/8/18 - Sarah Riepenhausen
Titular de derechos de autor

Fuzhou General Hospital

Subido en

21 de agosto de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Renal Cell Carcinoma NCT00862303

Eligibility Renal Cell Carcinoma NCT00862303

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven renal cell carcinoma
Descripción

Histological determination of a renal cell carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0449575
UMLS CUI [1,2]
C0007134
age: > 18
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
who- ecog performance status 0-1
Descripción

ECOG perfomance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
at least one measurable tumor lesions according to the recist criteria.
Descripción

Measurable tumor lesions according to the recist criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1709926
UMLS CUI [1,2]
C1513041
life expectancy more than 3 months
Descripción

Life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal/squamous cell carcinomas of the skin).
Descripción

History of another neoplastic disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2735087
patients with metastatic disease in the central nervous system (cns).
Descripción

CNS metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0686377
patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.
Descripción

Concomitant significant illness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0243087
UMLS CUI [2]
C2945656
UMLS CUI [3]
C0004096
UMLS CUI [4]
C0002962
UMLS CUI [5]
C0018802
patients with acute or chronic infection including hiv.
Descripción

Acute or chronic infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3714514
UMLS CUI [2]
C0019682
patients who are pregnant or nursing.
Descripción

Pregnancy or breast feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.
Descripción

Prior antineoplastic therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2346834
patients who receive corticosteroids or other immunosuppressive agents.
Descripción

Corticoid or immunosuppressive therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0239126
patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.
Descripción

Concomitant autoimmune diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0409974
UMLS CUI [3]
C0003873
UMLS CUI [4]
C0920350

Similar models

Eligibility Renal Cell Carcinoma NCT00862303

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Histological determination of a renal cell carcinoma
Item
histologically proven renal cell carcinoma
boolean
C0449575 (UMLS CUI [1,1])
C0007134 (UMLS CUI [1,2])
Age
Item
age: > 18
boolean
C0001779 (UMLS CUI [1])
ECOG perfomance status
Item
who- ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Measurable tumor lesions according to the recist criteria
Item
at least one measurable tumor lesions according to the recist criteria.
boolean
C1709926 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
Life expectancy
Item
life expectancy more than 3 months
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of another neoplastic disease
Item
patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal/squamous cell carcinomas of the skin).
boolean
C2735087 (UMLS CUI [1])
CNS metastasis
Item
patients with metastatic disease in the central nervous system (cns).
boolean
C0686377 (UMLS CUI [1])
Concomitant significant illness
Item
patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.
boolean
C0243087 (UMLS CUI [1])
C2945656 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
C0002962 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
Acute or chronic infection
Item
patients with acute or chronic infection including hiv.
boolean
C3714514 (UMLS CUI [1])
C0019682 (UMLS CUI [2])
Pregnancy or breast feeding
Item
patients who are pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Prior antineoplastic therapy
Item
patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.
boolean
C2346834 (UMLS CUI [1])
Corticoid or immunosuppressive therapy
Item
patients who receive corticosteroids or other immunosuppressive agents.
boolean
C0021079 (UMLS CUI [1])
C0239126 (UMLS CUI [2])
Concomitant autoimmune diseases
Item
patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.
boolean
C0004364 (UMLS CUI [1])
C0409974 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0920350 (UMLS CUI [4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial